Princeton, New Jersey16 days ago
D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. This individual will work closely with senior leadership on workforce planning, hiring managers on the identification of talent, current and potential candidates during the recruitment process, and external partners to help create an efficient and successful candidate experience.